Eric Thomas Schmidt - Net Worth and Insider Trading
Eric Thomas Schmidt Net Worth
The estimated net worth of Eric Thomas Schmidt is at least $4 Million dollars as of 2024-11-13. Eric Thomas Schmidt is the CFO of Allogene Therapeutics Inc and owns about 1,253,141 shares of Allogene Therapeutics Inc (ALLO) stock worth over $4 Million. Details can be seen in Eric Thomas Schmidt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric Thomas Schmidt has not made any transactions after 2022-03-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eric Thomas Schmidt
Eric Thomas Schmidt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric Thomas Schmidt owns 3 companies in total, including Allogene Therapeutics Inc (ALLO) , Revolution Medicines Inc (RVMD) , and Relmada Therapeutics Inc (RLMD) .
Click here to see the complete history of Eric Thomas Schmidt’s form 4 insider trades.
Insider Ownership Summary of Eric Thomas Schmidt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALLO | Allogene Therapeutics Inc | 2022-03-15 | Chief Financial Officer |
| RVMD | Revolution Medicines Inc | 2020-06-17 | director |
| RLMD | Relmada Therapeutics Inc | 2019-12-19 | director |
Eric Thomas Schmidt Latest Holdings Summary
Eric Thomas Schmidt currently owns a total of 1 stock. Eric Thomas Schmidt owns 1,253,141 shares of Allogene Therapeutics Inc (ALLO) as of March 15, 2022, with a value of $4 Million.
Latest Holdings of Eric Thomas Schmidt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics Inc | 2022-03-15 | 1,253,141 | 2.84 | 3,558,920 |
Holding Weightings of Eric Thomas Schmidt
Eric Thomas Schmidt Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric Thomas Schmidt has made a total of 7 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Allogene Therapeutics Inc is the sale of 11,469 shares on March 15, 2022, which brought Eric Thomas Schmidt around $87,509.
Insider Trading History of Eric Thomas Schmidt
- 1
Eric Thomas Schmidt Trading Performance
Eric Thomas Schmidt Ownership Network
Ownership Network List of Eric Thomas Schmidt
Ownership Network Relation of Eric Thomas Schmidt
Eric Thomas Schmidt Owned Company Details
What does Allogene Therapeutics Inc do?
Who are the key executives at Allogene Therapeutics Inc?
Eric Thomas Schmidt is the Chief Financial Officer of Allogene Therapeutics Inc. Other key executives at Allogene Therapeutics Inc include director & 10 percent owner Arie Belldegrun , CHIEF FINANCIAL OFFICER Geoffrey M. Parker , and GENERAL COUNSEL Earl Martin Douglas .
Allogene Therapeutics Inc (ALLO) Insider Trades Summary
Over the past 18 months, Eric Thomas Schmidt made no insider transaction in Allogene Therapeutics Inc (ALLO). Other recent insider transactions involving Allogene Therapeutics Inc (ALLO) include a net sale of 37,281 shares made by Deborah M. Messemer , a net purchase of 1,724,137 shares made by Arie Belldegrun , and a net sale of 11,200 shares made by Franz B Humer .
In summary, during the past 3 months, insiders sold 0 shares of Allogene Therapeutics Inc (ALLO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 58,481 shares of Allogene Therapeutics Inc (ALLO) were sold and 1,724,327 shares were bought by its insiders, resulting in a net purchase of 1,665,846 shares.
Allogene Therapeutics Inc (ALLO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Allogene Therapeutics Inc Insider Transactions
Eric Thomas Schmidt Mailing Address
Above is the net worth, insider trading, and ownership report for Eric Thomas Schmidt. You might contact Eric Thomas Schmidt via mailing address: C/o Allogene Therapeutics, Inc., 210 East Grand Avenue, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
